Brief: Genetic Signatures Posts Sales (Unaudited) For Q2 Of Fy2024
Jan 31 (Reuters) - Genetic Signatures Ltd GSS.AX :
* SALES OF A$2.0 MILLION (UNAUDITED) FOR Q2 OF FY2024
Source text for Eikon: ID:nASX45dSqS
Further company coverage: GSS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genetic Signatures
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Australia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: Genetic Signatures Receives Request From BCAL Diagnostics To Call General Meeting Of Shareholders
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: Genetic Signatures Announces Board Changes